Sarepta Therapeutics Inc (SRPT)
118.97
-0.50
(-0.42%)
USD |
NASDAQ |
Dec 20, 16:00
119.11
+0.14
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Quarterly): 1.221B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals Inc | 185.44M |
| Eli Lilly and Co | 14.24B |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Catalyst Pharmaceuticals Inc | 660.94M |
| Vertex Pharmaceuticals Inc | 15.63B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Total Liabilities (Quarterly) | 2.379B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |